Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asahi Kasei Bioprocess (formerly Asahi Kasei TechniKrom) is a leading provider of bioprocessing equipment and fluid management solutions for the global life sciences industry. The company specializes in the engineering and manufacture of automated chromatography systems, in-line buffer dilution (IBD) platforms, and filtration skids used in the production of biopharmaceuticals. Their technology is essential for the downstream processing of modalities such as monoclonal antibodies, recombinant proteins, and oligonucleotides. By integrating TechniKrom’s fluid handling expertise with Asahi Kasei’s filtration legacy, the company offers comprehensive solutions for scaling up drug manufacturing from pilot to commercial stages. Headquartered in Glenview, Illinois, they support pharmaceutical companies in optimizing process efficiency and ensuring product purity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Asahi Kasei TechniKrom.